Overview of Basic Immunology for Clinical Investigators

被引:0
作者
Stephen, Bettzy [1 ]
Hajjar, Joud [2 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA
来源
IMMUNOTHERAPY | 2017年 / 995卷
关键词
Adaptive; CTLA-4; Immune checkpoints; Tumor immunotherapy; Innate; PD-1; T cells; REGULATORY T-CELLS; TUMOR-ASSOCIATED MACROPHAGES; MAST-CELLS; INNATE IMMUNITY; CANCER-IMMUNOTHERAPY; SIGNALING PATHWAYS; BREAST-CANCER; SUPPRESSOR-CELLS; HUMAN-ANTIBODIES; HUMAN BASOPHILS;
D O I
10.1007/978-3-319-53156-4_1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Tumor exists as a complex network of structures with an ability to evolve and evade the host immune surveillance mechanism. The immune milieu which includes macrophages, dendritic cells, natural killer cells, neutrophils, mast cells, B cells, and T cells are found in the core, the invasive margin, or the adjacent stromal or lymphoid component of the tumor. The immune infiltrate is heterogeneous and varies within a patient and between patients of the same tumor histology. The location, density, functionality, and the cross talk between the immune cells in the tumor microenvironment influence the nature of immune response, prognosis, and treatment outcomes in cancer patients. Therefore, an understanding of the characteristics of the immune cells and their role in tumor immune surveillance is of paramount importance to identify immune targets and to develop novel immune therapeutics in the war against cancer. In this chapter, we provide an overview of the individual components of the human immune system and the translational relevance of predictive biomarkers.
引用
收藏
页码:1 / 31
页数:31
相关论文
共 192 条
[81]   CD28 AND CTLA-4 HAVE OPPOSING EFFECTS ON THE RESPONSE OF T-CELLS TO STIMULATION [J].
KRUMMEL, MF ;
ALLISON, JP .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (02) :459-465
[82]   Single-Institution Experience With Ipilimumab in Advanced Melanoma Patients in the Compassionate Use Setting Lymphocyte Count After 2 Doses Correlates With Survival [J].
Ku, Geoffrey Y. ;
Yuan, Jianda ;
Page, David B. ;
Schroeder, Sebastian E. A. ;
Panageas, Katherine S. ;
Carvajal, Richard D. ;
Chapman, Paul B. ;
Schwartz, Gary K. ;
Allison, James P. ;
Wolchok, Jedd D. .
CANCER, 2010, 116 (07) :1767-1775
[83]   MONOCLONAL ANTIBODIES DEFINING DISTINCTIVE HUMAN T-CELL SURFACE-ANTIGENS [J].
KUNG, PC ;
GOLDSTEIN, G ;
REINHERZ, EL ;
SCHLOSSMAN, SF .
SCIENCE, 1979, 206 (4416) :347-349
[84]   Control of PD-L1 Expression by Oncogenic Activation of the AKT-mTOR Pathway in Non-Small Cell Lung Cancer [J].
Lastwika, Kristin J. ;
Wilson, Willie, III ;
Li, Qing Kay ;
Norris, Jeffrey ;
Xu, Haiying ;
Ghazarian, Sharon R. ;
Kitagawa, Hiroshi ;
Kawabata, Shigeru ;
Taube, Janis M. ;
Yao, Sheng ;
Liu, Linda N. ;
Gills, Joell J. ;
Dennis, Phillip A. .
CANCER RESEARCH, 2016, 76 (02) :227-238
[85]   Mast cell-mediated apoptosis of endothelial cells in vitro:: A paracrine mechanism involving TNF-α-mediated down-regulation of bcl-2 expression [J].
Lätti, S ;
Leskinen, M ;
Shiota, N ;
Wang, YF ;
Kovanen, PT ;
Lindstedt, KA .
JOURNAL OF CELLULAR PHYSIOLOGY, 2003, 195 (01) :130-138
[86]   Mast cell chymase induces smooth muscle cell apoptosis by a mechanism involving fibronectin degradation and disruption of focal adhesions [J].
Leskinen, MJ ;
Lindstedt, KA ;
Wang, YF ;
Kovanen, PT .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (02) :238-243
[87]   Deletion of the CD4 silencer element supports a stochastic mechanism of thymocyte lineage commitment [J].
Leung, RKM ;
Thomson, K ;
Gallimore, A ;
Jones, E ;
Van den Broek, M ;
Sierro, S ;
Alsheikhly, AR ;
McMichael, A ;
Rahemtulla, A .
NATURE IMMUNOLOGY, 2001, 2 (12) :1167-1173
[88]   Regulation of PD-1, PD-L1, and PD-L2 expression during normal and autoimmune responses [J].
Liang, SC ;
Latchman, YE ;
Buhlmann, JE ;
Tomczak, MF ;
Horwitz, BH ;
Freeman, GJ ;
Sharpe, AH .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2003, 33 (10) :2706-2716
[89]   The Complex Role of Neutrophils in Tumor Angiogenesis and Metastasis [J].
Liang, Wei ;
Ferrara, Napoleone .
CANCER IMMUNOLOGY RESEARCH, 2016, 4 (02) :83-91
[90]   Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy [J].
Lin, EY ;
Nguyen, AV ;
Russell, RG ;
Pollard, JW .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (06) :727-739